Prostate Cancer: The Year in Review - Fred Saad
Fred Saad, MD FRCS, presents the Year in Review for Prostate Cancer 2015 as presented at the ASCO GU 2016.
Fred Saad MD FRCS, is Full Professor and Chief of Urology and Director of G-U Oncology at the University of Montreal Hospital Centers (CHUM). He holds the U of M Endowed Chair in Prostate Cancer Research and is Director of the molecular oncology research lab in Prostate Cancer. He is the past Chair of the National Cancer Institute of Canada G-U Group and the Canadian Urologic Oncology Group. Dr Saad has been involved in most of the important clinical trials in advanced prostate cancer over the last 20 years and presently sits on 7 steering committees of international clinical trials. He serves on several international guidelines committees and sits on 7 editorial boards, including Lancet Oncology, JAMA Oncology, Nature Urology, Urology as well as Current Oncology. He has published 350 peer-reviewed articles with over 32,000 citations, as well as over 1000 scientific abstracts, 8 books and over 50 book chapters. Dr Saad’s research interests include molecular prognostic markers, mechanisms of progression and new therapeutics in prostate cancer. He has over 40 clinical and basic research projects ongoing and has received over 30 million dollars in research grants to date. In 2014 he received the lifetime achievement award for research from the CHUM Research Center.